AdvaMed's Next Chairman Is Abbott Exec Jim Mazzo
This article was originally published in The Gray Sheet
Executive Summary
Abbott Medical Optics' chief exec Jim Mazzo is on deck to be the next chairman of AdvaMed, succeeding the outgoing Michael Mussallem
You may also be interested in...
China Is Top International Priority For AdvaMed's New Chairman
U.S. medical device association AdvaMed's new chairman, Jim Mazzo, cites regulatory roadblocks in China as the most important international marketing issue facing U.S. device manufacturers
FDA Hints At Possible 510(k) Tweaks At Public Meeting
FDA is considering changing how predicate devices are selected for 510(k) submissions and beefing up its post-market authorities for 510(k)-cleared products, agency reps suggested at a Feb. 18 public meeting
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip